Wu, Chen-Han Wilfred http://orcid.org/0000-0003-4827-9920
Huang, Yu-Ren
Bodner, Donald
Schumacher, Fredrick R.
Baum, Michelle
Hildebrandt, Friedhelm http://orcid.org/0000-0002-7130-0030
Article History
First Online: 17 April 2024
Competing interests
: C.-H.W.W. has clinical trials with Moderna Tx and is in the executive committee of the Harrington Scholar-Innovator award programme. D.B. has Fortec litho stock. M.B. has clinical trials with NovoNordisk, is a scientific advisor with NovoNordisk, has an ongoing post-marketing study with Alynylam, is a scientific advisor with Alnylam and is a medical advisor with Cantero (previously Orfan) and Chinook. F.H. has a University of Michigan patent, a patent of NPHP4 planned and is part of the Brigham & Women’s Hospital Boards course. The other authors declare no competing interests.